Nevertheless, understanding the precise role of TBL1XR1 in the progression of NPC and activation of the NF-κB signaling will not only advance our knowledge of the mechanisms underlying NPC progression, but also help establish TBL1XR1 as a biomarker for clinical outcome and a potential therapeutic target in NPC. Here, TBL1XR1 is linked to nasopharyngeal carcinoma.